Immunohistochemical Profiling of Ovarian Tumors
Author Information
Author(s): Ouellet Véronique, Ling Tak Hay, Normandin Karine, Madore Jason, Lussier Christian, Barrès Véronique, Bachvarov Dimcho, Rancourt Claudine, Tonin Patricia N, Provencher Diane M, Mes-Masson Anne-Marie
Primary Institution: Centre de recherche du centre hospitalier de l'Université de Montréal (CHUM)
Hypothesis
The study aims to evaluate the protein expression of selected candidates in benign, low malignant potential, and low grade serous epithelial ovarian tumors.
Conclusion
The study highlights significant differences in protein expression among benign, low malignant potential, and low grade serous ovarian tumors.
Supporting Evidence
- Statistically significant differences in protein expression were observed for Ccnb1 when comparing benign to low malignant potential tumors.
- Trail was significantly overexpressed in malignant tumors compared to benign tumors.
- Lower levels of p21 were found in low grade tumors compared to benign and low malignant potential tumors.
Takeaway
Researchers looked at different types of ovarian tumors to see how certain proteins are expressed, helping to understand their differences.
Methodology
The study used a tissue array composed of 27 benign, 78 low malignant potential, and 23 low grade tumors to evaluate protein expression.
Limitations
The study's findings may not be generalizable due to the limited number of low grade tumors.
Participant Demographics
Mean age of participants was 48 years for benign tumors, 49 years for low malignant potential tumors, and 52 years for low grade tumors.
Statistical Information
P-Value
0.001, 0.003, 0.01, 0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website